Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Investigator attribution was split into a standalone name entry and new metadata lines (Last verified, Last known status). The page also introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized label for Intervention/Treatment.
    Difference
    2%
    Check dated 2026-06-12T16:50:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision tag labeled Revision: v3.5.5 appears, replacing the prior Revision: v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-05T13:12:50.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, updating the revision label from the previous v3.5.3. This reflects a new entry in the page's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T04:45:21.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The interface revision tag was updated from v3.5.2 to v3.5.3. This reflects a minor platform update with no changes to the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-04-30T18:52:58.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.5.2 now appears on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:10:51.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.5.0 and removed Revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-18T19:56:34.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.